121 related articles for article (PubMed ID: 6941038)
1. Herpes simplex virus type 2 and human cervical cancer: relationship between cellular and immune assays for the detection of previous infection.
Smith JW; Torres JE; Holmquist ND
J Natl Cancer Inst; 1981 Jun; 66(6):1031-6. PubMed ID: 6941038
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
Christenson B; Espmark A
Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
[TBL] [Abstract][Full Text] [Related]
3. Association of Herpes simplex virus (HSV) with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens.
Smith JW; Torres JE; Holmquist ND
Am J Epidemiol; 1979 Aug; 110(2):141-7. PubMed ID: 223438
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of association of herpes simplex virus and human papillomavirus infection with cervical neoplasia in women exposed to diethylstilbestrol in utero.
Adam E; Kaufman RH; Adler-Storthz K; Melnick JL; Dreesman GR
Int J Cancer; 1985 Jan; 35(1):19-26. PubMed ID: 2981778
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
Najem SN; Vestergaard BF; Potter CW
Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
Seth P; Prakash SS; Ghosh D
Int J Cancer; 1978 Dec; 22(6):708-14. PubMed ID: 214407
[TBL] [Abstract][Full Text] [Related]
7. Estimation of type-specific neutralizing antibody to herpes simplex virus type 2 in uterine cervical cancer patients by a new absorption method.
Kawana T; Yoshino K
Microbiol Immunol; 1980; 24(12):1163-74. PubMed ID: 7219207
[TBL] [Abstract][Full Text] [Related]
8. [Etiological role of the herpes simplex virus in causing cervical cancer].
Posevaia TA; Shubladze AK; Grigor'ev VV; Ugriumov EP; Kitsak VIa
Vopr Virusol; 1979; (6):611-5. PubMed ID: 230645
[TBL] [Abstract][Full Text] [Related]
9. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
[TBL] [Abstract][Full Text] [Related]
10. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
[TBL] [Abstract][Full Text] [Related]
11. Immunology of herpes simplex virus infection: relevance to herpes simplex virus vaccines and cervical cancer.
Nahmias AJ; Shore SL; Kohl S; Starr SE; Ashman RB
Cancer Res; 1976 Feb; 36(2 pt 2):836-44. PubMed ID: 766960
[TBL] [Abstract][Full Text] [Related]
12. Infection with herpes-simplex viruses 1 and 2. II.
Nahmias AJ; Roizman B
N Engl J Med; 1973 Oct; 289(14):719-25. PubMed ID: 4353782
[TBL] [Abstract][Full Text] [Related]
13. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to Herpes simplex virus in Jewish women with cervical cancer and in healthy Jewish women of Israel.
Menczer J; Leventon-Kriss S; Modan M; Oelsner G; Gerichter CB
J Natl Cancer Inst; 1975 Jul; 55(1):3-6. PubMed ID: 169365
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
Chiphangwi JD
IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279
[TBL] [Abstract][Full Text] [Related]
16. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
Aurelian L; Kessler II; Rosenshein NB; Barbour G
Cancer; 1981 Jul; 48(2 Suppl):455-71. PubMed ID: 7023662
[TBL] [Abstract][Full Text] [Related]
17. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
Thiry L; Sprecher-Goldberger S; Hannecart-Pokorni E; Gould I; Bossens M
Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus and human cancer. III. Search for relationship of herpes simplex antibodies and cervical dysplasia and labial neoplasia.
Rotola A; Gerna G; Di Luca D; Virgili AR; Manservigi R; Cassai E
Tumori; 1983 Apr; 69(2):83-7. PubMed ID: 6304957
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus. An expanding relationship to human cancer.
Smith JW
J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
[TBL] [Abstract][Full Text] [Related]
20. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment.
Vonka V; Kanka J; Hirsch I; Závadová H; Krcmár M; Suchánková A; Rezácová D; Broucek J; Press M; Domorázková E
Int J Cancer; 1984 Jan; 33(1):61-6. PubMed ID: 6319297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
